Lenz Therapeutics has received approval from the Food and Drug Administration for Vizz (aceclidine ophthalmic solution) 1.44% ...

It is anticipated that Vizz, manufactured by Lenz Therapeutics, will become commercially available in the US by the end of ...

Vizz being approved by the FDA marks a step in the right direction for treating vision loss in an accessible way.

Detailed price information for Lenz Therapeutics Inc (LENZ-Q) from The Globe and Mail including charting and trades.

On Thursday, LENZ Therapeutics LENZ earned a positive adjustment to its Relative Strength (RS) Rating, from 89 to 92. Please watch the video at Investors.com - Find Top Growth Stocks With The IBD ...

Detailed price information for Lenz Therapeutics Inc (LENZ-Q) from The Globe and Mail including charting and trades.

The US Food and Drug Administration has approved Vizz eye drops. These drops improve near vision for adults over 40. Lenz ...

Shares of International Money Express, Inc. IMXI +56.3% Get Free Report rose sharply in pre-market trading after Western ...

Nucleic-acid therapeutics articles from across Nature Portfolio Nucleic acid therapeutics are based on nucleic acids or closely related chemical compounds. They include antisense oligonucleotides ...

Our data shows VIZZ (aceclidine 1.44%) received FDA approval in July 2025, positioning the once-daily, preservative-free ...